Cargando…

Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System

INTRODUCTION: The aim of this study was to determine the clinical efficacy of preprandial and postprandial Prandilin 25 (premixed insulin lispro 25) administration in patients with newly diagnosed type 2 diabetes mellitus (T2DM) using a continuous glucose monitoring (CGM) system. METHODS: This was a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yong, Ni, Wen-ji, Ding, BO, Xu, Xiang-hong, Ye, Lei, Ma, Jian-hua, Zhu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349270/ https://www.ncbi.nlm.nih.gov/pubmed/30610472 http://dx.doi.org/10.1007/s13300-018-0545-7

Ejemplares similares

Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System
por: Luo, Yong, et al.
Publicado: (2018)

Measurement of preprandial and postprandial urine calcium to creatinine ratios in male Miniature Schnauzers with and without urolithiasis
por: Carr, Susan V., et al.
Publicado: (2020)

Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA(1c) in individuals with and without diabetes
por: Færch, Kristine, et al.
Publicado: (2018)

Preprandial ghrelin is not affected by macronutrient intake, energy intake or energy expenditure
por: Paul, David R, et al.
Publicado: (2005)

Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin
por: Tura, Andrea, et al.
Publicado: (2015)

Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes
por: Liu, Bing-li, et al.
Publicado: (2018)

Continuous glucose monitoring in a patient with insulinoma presenting with unawareness of postprandial hypoglycemia
por: Nakajima, Rikako, et al.
Publicado: (2023)

Continuous Glucose Monitoring in Newly Diagnosed Type 2 Diabetes Patients Reveals a Potential Risk of Hypoglycemia in Older Men
por: Li, Feng-fei, et al.
Publicado: (2017)

Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting
por: Röhling, Martin, et al.
Publicado: (2019)

Time to peak postprandial glucose levels in childhood-onset diabetic patients analyzed with a continuous glucose monitoring system
por: Suzuki, Junichi, et al.
Publicado: (2013)

Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring
por: Oki, Yusuke, et al.
Publicado: (2018)

Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096)
por: Ratner, R, et al.
Publicado: (2011)

Postprandial Asymptomatic Glycemic Fluctuations after Gastrectomy for Gastric Cancer Using Continuous Glucose Monitoring Device
por: Ri, Motonari, et al.
Publicado: (2021)

Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women
por: Weickert, Martin O, et al.
Publicado: (2006)

Contributions of Fasting and Postprandial Glucose Concentrations to Haemoglobin A1c in Drug-Naïve Mal-Glucose Metabolism in Chinese Population Using Continuous Glucose Monitoring System
por: Yan, Rengna, et al.
Publicado: (2019)

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test
por: Holst, Jens J., et al.
Publicado: (2015)

Impact of Lifestyle Behaviors on Postprandial Hyperglycemia during Continuous Glucose Monitoring in Adult Males with Overweight/Obesity but without Diabetes
por: Kishimoto, Ichiro, et al.
Publicado: (2021)

Effect of High β-glucan Barley on Postprandial Blood Glucose Levels in Subjects with Normal Glucose Tolerance: Assessment by Meal Tolerance Test and Continuous Glucose Monitoring System
por: Higa, Mariko, et al.
Publicado: (2019)

Repeated Hypoglycemic Episodes with Postprandial Hyperinsulinemia after the Recovery from Acute Weight Loss Revealed by Continuous Glucose Monitoring and the Oral Glucose Tolerance Test
por: Masuda, Seizaburo, et al.
Publicado: (2017)

Individual Postprandial Glycemic Responses to Meal Types by Different Carbohydrate Levels and Their Associations with Glycemic Variability Using Continuous Glucose Monitoring
por: Song, Jiwoo, et al.
Publicado: (2023)

Oral administration of linoleic acid immediately before glucose load ameliorates postprandial hyperglycemia
por: Yamamoto, Yuta, et al.
Publicado: (2023)

The effects of postprandial glucose and insulin levels on postprandial endothelial function in subjects with normal glucose tolerance
por: Suzuki, Kazunari, et al.
Publicado: (2012)

Continuous glucose monitoring
por: Pandit, Kaushik
Publicado: (2012)

Administration of Jerusalem artichoke reduces the postprandial plasma glucose and glucose-dependent insulinotropic polypeptide (GIP) concentrations in humans
por: Takahashi, Hirokazu, et al.
Publicado: (2022)

Ultra-Rapid Lispro Improves Postprandial Glucose Control and Time in Range in Type 1 Diabetes Compared to Lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
por: Malecki, Maciej T., et al.
Publicado: (2020)

An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility Study
por: Oser, Tamara K, et al.
Publicado: (2022)

Postprandial Glucose: Marker or Risk Factor?
por: Avogaro, Angelo
Publicado: (2011)

Reference Values for Continuous Glucose Monitoring in Chinese Subjects
por: Zhou, Jian, et al.
Publicado: (2009)

Continuous Glucose Monitoring in the Hospital
por: Perez-Guzman, M. Citlalli, et al.
Publicado: (2021)

The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM
por: Dunseath, Gareth J., et al.
Publicado: (2021)

Postprandial glucagon-like peptide 1 secretion is associated with urinary albumin excretion in newly diagnosed type 2 diabetes patients
por: Song, Lu-Lu, et al.
Publicado: (2023)

Associations of Insulin Levels and Insulin Resistance With Urine Glucose Excretion Independent of Blood Glucose in Chinese Adults With Prediabetes and Newly Diagnosed Diabetes
por: Chen, Juan, et al.
Publicado: (2018)

Assessment of postprandial hyperglycemia and circadian fluctuation of glucose concentrations in diabetic dogs using a flash glucose monitoring system
por: Shea, Emily K., et al.
Publicado: (2021)

Effect of Cinnamon Tea on Postprandial Glucose Concentration
por: Bernardo, Maria Alexandra, et al.
Publicado: (2015)

Newly Diagnosed Idiopathic Thrombocytopenia Post COVID-19 Vaccine Administration
por: Idogun, Precious O, et al.
Publicado: (2021)

Timing of bevacizumab administration after biopsy for unresectable newly diagnosed glioblastoma
por: Matsuda, Masahide, et al.
Publicado: (2022)

Continuous Glucose Monitoring Enabled by Fluorescent Nanodiamond Boronic Hydrogel
por: Zhang, Jian, et al.
Publicado: (2023)

Glycemic fluctuations caused by COVID-19: Results from continuous glucose monitoring
por: Shen, Yun, et al.
Publicado: (2021)

Stabilization of postprandial blood glucose fluctuations by addition of glucagon like polypeptide-analog administration to intensive insulin therapy
por: Ogawa, Susumu, et al.
Publicado: (2015)

Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin
por: Masuda, Daisaku, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mav2r66kl5dro26u9qquo5g0k6